ROBIN HOWARD W — SEC insider filings

SEC reporting owner CIK 1206869. 39 insider filings on record with FilingPulse; latest filed 2026-11-19.

Transaction summary — filings shown

Covers all 39 filings on record, filed 2020-08-19 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NEKTAR THERAPEUTICS (NKTR)President & CEO, Director39—50 legs · 1,024,202 sh · $13,694,31627

Insider filings — ROBIN HOWARD W

FiledFormIssuerReported transactionsSource
2026-11-194NEKTAR THERAPEUTICS (NKTR)Sale (S): 429 @ $35.85EDGAR
2026-08-204NEKTAR THERAPEUTICS (NKTR)Sale (S): 418 @ $71.98EDGAR
2026-07-244NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 57,200 (derivative) @ $0EDGAR
2026-06-184NEKTAR THERAPEUTICS (NKTR)Sale (S): 5,303 @ $59.97 · Sale (S): 4,697 @ $60.71 · Sale (S): 5,500 @ $60.81 · Sale (S): 4,500 @ $61.65EDGAR
2026-05-214NEKTAR THERAPEUTICS (NKTR)Sale (S): 444 @ $65.51EDGAR
2026-02-204NEKTAR THERAPEUTICS (NKTR)Sale (S): 423 @ $73EDGAR
2025-12-234NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 21,667 @ $0 · Grant/award (A): 86,667 (derivative) @ $0EDGAR
2025-11-254NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 7,110 @ $0 · Sale (S): 2,207 @ $54.28 · Grant/award (A): 12,170 (derivative) @ $0EDGAR
2025-09-114NEKTAR THERAPEUTICS (NKTR)Sale (S): 2,100 @ $45.16 · Sale (S): 1,200 @ $46.41 · Sale (S): 2,156 @ $47.49 · Sale (S): 1,210 @ $48.18EDGAR
2025-09-084NEKTAR THERAPEUTICS (NKTR)Sale (S): 1,923 @ $32.37 · Sale (S): 1,496 @ $33.54 · Sale (S): 613 @ $34.40 · Sale (S): 1,134 @ $35.80 · Sale (S): 3,304 @ $37.87 · Sale (S): 2,226 @ $38.82 · +1 moreEDGAR
2025-09-044NEKTAR THERAPEUTICS (NKTR)Sale (S): 1,500 @ $30.16EDGAR
2025-08-214NEKTAR THERAPEUTICS (NKTR)Sale (S): 1,573 @ $26.59 · Grant/award (A): 86,666 (derivative) @ $0EDGAR
2025-05-214NEKTAR THERAPEUTICS (NKTR)Sale (S): 23,208 @ $0.67EDGAR
2025-02-214NEKTAR THERAPEUTICS (NKTR)Sale (S): 23,774 @ $1.01EDGAR
2024-12-194NEKTAR THERAPEUTICS (NKTR)Sale (S): 46,995 @ $1.01 · Sale (S): 85,035 @ $0.99EDGAR
2024-12-174NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 410,625 @ $0 · Grant/award (A): 821,250 (derivative) @ $0 · Grant/award (A): 1,300,000 (derivative) @ $0EDGAR
2024-11-204NEKTAR THERAPEUTICS (NKTR)Sale (S): 16,278 @ $1.01EDGAR
2024-08-204NEKTAR THERAPEUTICS (NKTR)Sale (S): 14,881 @ $1.28EDGAR
2024-05-204NEKTAR THERAPEUTICS (NKTR)Sale (S): 16,650 @ $1.75EDGAR
2024-02-224NEKTAR THERAPEUTICS (NKTR)Sale (S): 20,033 @ $0.68EDGAR
2023-12-154NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 1,300,000 (derivative) @ $0EDGAR
2023-11-204NEKTAR THERAPEUTICS (NKTR)Sale (S): 19,877 @ $0.49EDGAR
2023-08-174NEKTAR THERAPEUTICS (NKTR)Sale (S): 19,998 @ $0.78EDGAR
2023-05-174NEKTAR THERAPEUTICS (NKTR)Sale (S): 20,361 @ $0.72EDGAR
2023-02-174NEKTAR THERAPEUTICS (NKTR)Sale (S): 19,635 @ $3EDGAR
2022-11-184NEKTAR THERAPEUTICS (NKTR)Sale (S): 38,014 @ $3.57EDGAR
2022-08-174NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 410,625 @ $0 · Sale (S): 13,759 @ $4.76 · Grant/award (A): 821,250 (derivative) @ $0EDGAR
2022-05-174NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 68,450 @ $0 · Sale (S): 36,529 @ $3.95EDGAR
2022-02-184NEKTAR THERAPEUTICS (NKTR)Sale (S): 12,480 @ $10.95EDGAR
2021-12-204NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 126,050 @ $0 · Grant/award (A): 223,750 (derivative) @ $0EDGAR
2021-11-174NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 94,100 @ $0 · Sale (S): 42,773 @ $13.16EDGAR
2021-10-144NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 167,650 (derivative) @ $0EDGAR
2021-08-184NEKTAR THERAPEUTICS (NKTR)Sale (S): 11,515 @ $13.83EDGAR
2021-05-194NEKTAR THERAPEUTICS (NKTR)Sale (S): 11,560 @ $18.30EDGAR
2021-02-184NEKTAR THERAPEUTICS (NKTR)Sale (S): 11,495 @ $22.37EDGAR
2021-02-044NEKTAR THERAPEUTICS (NKTR)Option exercise (M): 150,000 @ $8.80 · Sale (S): 139,500 @ $19.69 · Sale (S): 9,900 @ $20.84 · Sale (S): 600 @ $21.59 · Option exercise (M): 75,000 @ $8.80 · Option exercise (M): 75,000 @ $8.80 · +8 moreEDGAR
2020-12-224NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 106,650 @ $0 · Grant/award (A): 190,650 (derivative) @ $0EDGAR
2020-11-184NEKTAR THERAPEUTICS (NKTR)Sale (S): 11,975 @ $16.93EDGAR
2020-08-194NEKTAR THERAPEUTICS (NKTR)Sale (S): 11,885 @ $19.67EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1206869 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs